Health Care • Medical/Dental Instruments
$15.77 ▲ +0.46
(+3.01%)
MKT CAP: $430.6M • VOL: 58.6K
52W L $9 52W H $17
CARL // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 |
|---|---|---|
| Revenue (Total Sales) | $50.5M | $27.2M |
| YoY Revenue Growth % | — | — |
| Gross Profit | $38.0M | $20.0M |
| Gross Margin % | 75.3% | 73.8% |
| Research & Development (R&D) | — | — |
| Operating Income (EBIT) | -$30.6M | -$24.1M |
| Operating Margin % | -60.5% | -80.0% |
| Net Income (GAAP) | -$29.6M | -$24.3M |
| EBITDA (Normalized) | -$30.1M | -$24.0M |
| Diluted EPS ($/sh) | — | — |
| Operating Cash Flow (OCF) | -$29.0M | -$25.5M |
| Capital Expenditures (CapEx) | $642.0K | $180.0K |
| Free Cash Flow (FCF) | -$29.6M | -$25.6M |
| FCF Margin % | -58.6% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% |
| Cash & Short-Term Equivalents | $85.8M | $40.1M |
| Total Debt (Short + Long Term) | — | — |
| Total Stockholders' Equity | $98.9M | -$70.6M |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CARL.